MVZ Labor Krone GbR, Bad Salzuflen.
Society for Epilepsy Research; and.
Ther Drug Monit. 2021 Jun 1;43(3):394-400. doi: 10.1097/FTD.0000000000000890.
Drug concentrations of antiepileptic drugs (AEDs) are routinely determined from blood serum or plasma at trough levels (before intake of morning dose). In capillary blood collection, blood is taken from the fingertip with the aid of a disposable tool and dried on absorbent material. The volumetric absorptive microsampling technique offers several advantages over the use of filter paper cards. The aim of this study was to determine conversion factors for the estimation of AED serum concentrations from capillary blood concentrations.
Venous and capillary blood samples were collected from adult inpatients with epilepsy who were treated with lacosamide (LCM, n = 30), lamotrigine (LTG, n = 40), and/or levetiracetam (LEV, n = 36). A validated liquid chromatography-mass spectrometry (LC-MS) method for dried blood samples for these AEDs was compared with routine serum laboratory methods. Method agreement was evaluated using different regression techniques, and the conversion factors were calculated.
Regression analyses revealed a linear relationship between serum and capillary blood concentrations for all 3 AEDs (r ≥ 0.95). For LTG, the regression intercept was significantly different from 0, indicating that the relationship was linear, but not necessarily proportional. Although LEV and LCM concentrations tended to be lower in capillary blood than in serum (mean ratio of serum concentration to capillary blood concentration: 1.14 and 1.22, respectively), LTG concentrations were higher in capillary blood (mean ratio = 0.85).
The estimation of serum concentrations from measured capillary blood concentrations is feasible for LCM, LTG, and LEV. A simple ratio approach using the mean ratio and Passing-Bablok regression showed the best results for all 3 AEDs. The volumetric absorptive microsampling technique facilitates the quantitative sample collection of capillary blood and overcomes the drawbacks associated with the classical dried blood spot technique.
抗癫痫药物(AED)的药物浓度通常在谷值水平(早晨剂量前)从血清或血浆中测定。在毛细血管血采集过程中,使用一次性工具从指尖采血并在吸收材料上干燥。体积吸收微采样技术相对于使用滤纸卡具有多个优势。本研究旨在确定从毛细血管血浓度估算 AED 血清浓度的换算因子。
从接受拉科酰胺(LCM,n = 30)、拉莫三嗪(LTG,n = 40)和/或左乙拉西坦(LEV,n = 36)治疗的癫痫成年住院患者中采集静脉和毛细血管血样。与常规血清实验室方法相比,比较了这些 AED 的干血样本的验证液相色谱-质谱(LC-MS)方法。使用不同的回归技术评估方法的一致性,并计算转换因子。
回归分析显示所有 3 种 AED 的血清和毛细血管血浓度之间呈线性关系(r ≥ 0.95)。对于 LTG,回归截距与 0 显著不同,表明关系是线性的,但不一定是比例关系。尽管 LEV 和 LCM 浓度在毛细血管血中比在血清中倾向于更低(血清浓度与毛细血管血浓度的平均比值分别为 1.14 和 1.22),但 LTG 浓度在毛细血管血中更高(平均比值=0.85)。
从测量的毛细血管血浓度估算血清浓度对于 LCM、LTG 和 LEV 是可行的。使用平均比值和 Passing-Bablok 回归的简单比值方法显示了所有 3 种 AED 的最佳结果。体积吸收微采样技术便于定量采集毛细血管血,克服了经典干血斑技术的缺点。